Moreover, another study on human NSCLC cell lines, HCC827 and H1650, demonstrated that PPARγ agonists sensitize PTEN-deficient lung cancer cells to EGFR TKIs via autophagy induction [397]. This evidence concerns the gene EGFR and lung cancer.